As KRAS-mutated tumors are known to have high ROS levels and are more vulnerable to oxidative stress (25), it is possible that, in addition to DNA-replication regulation, the controlling effects of BCL6 on ROS levels might also contribute to the tumor-promoting effects of BCL6 in KRAS-mutant cancer cells. This evidence concerns the gene BCL6 and cancer.